Patents
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
11/2009
11/26/2009WO2009141659A1 Depsipeptides and their therapeutic use
11/26/2009WO2009141658A1 Depsipeptides and their therapeutic use
11/26/2009WO2009141657A1 Depsipeptides and their therapeutic use
11/26/2009WO2009140765A1 Selective caspase inhibitors and uses thereof
11/26/2009WO2006009674A8 Macrocyclic modulators of the ghrelin receptor
11/26/2009WO2006009645A8 Methods of using macrocyclic modulators of the ghrelin receptor
11/26/2009US20090291998 Eponemycin and epoxomicin analogs and uses thereof
11/26/2009US20090291902 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
11/26/2009US20090291899 Selective Modulation of Receptor Signalling
11/26/2009CA2725278A1 Depsipeptides and their therapeutic use
11/26/2009CA2724818A1 New optically pure compounds for improved therapeutic efficiency
11/26/2009CA2724788A1 Hepatoprotectant acetaminophen mutual prodrugs
11/26/2009CA2724785A1 Selective caspase inhibitors and uses thereof
11/26/2009CA2720729A1 Novel macrocyclic inhibitors of hepatitis c virus replication
11/25/2009EP2123666A1 Peptide
11/25/2009EP2123665A2 Inhibitors of interleukin-1Beta converting enzyme
11/25/2009EP2123328A1 Galanthamine derivatives, methods for their obtaining and use
11/25/2009EP2121922A2 Biologically active molecules, particularly based on pna and sirna, method for the cell-specific activation thereof, and application kit to be administered
11/25/2009EP2121729A1 Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture
11/25/2009EP2121728A1 Crystalline d-isoglutamyl-d-tryptophan and the mono ammonium salt of d-isoglutamyl- d-tryptophan
11/25/2009EP2121727A1 Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan
11/25/2009EP1618106B1 Carbacephem beta-lactam antibiotics
11/25/2009EP0954585B1 Human telomerase reverse transcriptase promoter
11/25/2009CN101589056A Depsipeptides and their therapeutic use
11/24/2009US7622556 Modified cytokines for use in cancer therapy
11/24/2009US7622446 Polypeptides, derivatives and uses thereof
11/24/2009US7622272 Treating cell proliferation disease; aberrant fetoplacental growth; cancer
11/24/2009US7622263 Kit for immobilizing organic substance, organic substance-immobilized structure, and manufacturing methods therefor
11/24/2009US7622105 Conjugation product of a cytokine selected from tumor necrosis factor and interferon gamma and a ligand of CD13 receptor; antitumor agents
11/24/2009CA2256391C Anticoagulant peptidyl-arginine aldehyde derivatives
11/24/2009CA2201105C Inhibitor of stem cell proliferation and uses thereof
11/19/2009US20090286852 RNA containing modified nucleosides and methods of use thereof
11/19/2009US20090286747 Mntf peptide compositions and methods of use
11/19/2009US20090286745 Inhibition of alpha-synuclein aggregation
11/19/2009US20090286316 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
11/19/2009US20090285774 Hepatitis C Virus Inhibitors
11/18/2009EP2118091A1 Pyrimidine substituted macrocyclic hcv inhibitors
11/18/2009EP2118080A1 Macrocyclic ghrelin receptor modulators and methods of using the same
11/18/2009EP2117541A1 Compounds and compositions as channel activating protease inhibitors
11/18/2009EP2117537A1 Compounds and compositions as channel activating protease inhibitors
11/18/2009EP1207873B1 Methods of inhibiting osteoclast activity
11/18/2009CN101583611A Inhibitors of hepatitis C virus
11/18/2009CN101580536A Macrocyclic ns-3 serine protease inhibitors of hepatitis c virus comprising alkyl and aryl alanine p2 moieties
11/18/2009CN101580535A Hcv protease inhibitors
11/18/2009CN100560568C Cyclin imide peptidyl metalloprotease inhibitor and its application
11/17/2009USRE40988 infections caused by HIV-1 or HIV-2; pain; cancers; anorexia nervosa; bulimia; cachexia; obesity; diabetes; asthma; Parkinson's disease; both acute and congestive heart failure; hypotension; hypertension; urinary retention; osteoporosis; angina pectoris; myocardial infarction; ulcers
11/17/2009US7619094 Ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virus
11/17/2009US7619092 Such as (2R,4S)-1-{N-(3,5-bistrifluoromethylbenzyl)-N-methyl}-aminocarbonyl-2-(4-fluoro-2-methylphenyl)-4-(2-hydroxyethoxy)-piperidine; tachykinin receptor antagonists
11/17/2009US7619058 Epitope/peptide recognized by HLA-A2402-restricted Ep-CAM-specific CTL and use of the same
11/17/2009US7619057 Cancer antigen peptide and/or major histocompatibility complex binding sites for use as tools in detection and tretment of cell proliferative disorders; immunotherapy; genetic vaccine
11/17/2009US7618945 inhibiting platelet aggregation; for treatment of thrombosis, restenosis, hypertension, heart failure, arrhythmia, inflammation, angina, stroke, atherosclerosis, ischemic conditions, angiogenesis, cancer, and neurodegenerative disorders
11/17/2009US7618937 Macromolecular antifouling chimeric compositions or coatings comprising peptide or polypeptide anchor moiety or component coupled to peptoid or polypeptoid moiety or component; inhibits protein adsorption or cell fouling of surfaces onto which composition is coated; medical devices; inhibits biofouling
11/17/2009US7618796 Industrially producing dipeptides easily and inexpensively without going through a complex synthesis; allowing a protein having proline iminopeptidase activity to act on an L-amino acid ester and an L-amino acid to form the dipeptide
11/17/2009CA2362878C N-[n-(3,3-dimethylbutyl)-l-.alpha.-aspartyl]-l-phenylalanine 1-methyl ester agglomerate
11/17/2009CA2230949C Synthetic peptides that inhibit il-6 activity
11/12/2009WO2009137432A1 A method for preparing macrocycles
11/12/2009WO2009136752A2 Novel peptide for augmenting brain-derived neutrotrophic factor (bdnf) protein expression in hippocampal neurons, hippocampal tissue and cerebral-cortex tissue
11/12/2009WO2009136290A1 Functionalized pyrrolidines and use thereof as iap inhibitors
11/12/2009US20090281042 Compositions and methods using same for the detection of viruses
11/12/2009US20090280165 Compounds that bind alpha5beta1 integrin and methods of use
11/12/2009US20090280117 Methods for the treatment or prevention of immune disorders using anti-cd40 antibodies
11/12/2009CA2722867A1 A method for preparing macrocycles
11/11/2009EP2116599A1 Reagent for introduction of protein or gene
11/11/2009EP2114986A1 Template-fixed peptidomimetics
11/11/2009EP2114924A2 Co-crystals and pharmaceutical compositions comprising the same
11/11/2009EP2114427A1 Peptides for treatment of conditions associated with nitric oxide
11/11/2009EP1713823B1 Hcv ns-3 serine protease inhibitors
11/11/2009EP1498421B1 Gamma-secretase inhibitors
11/11/2009EP1255726B1 (r)-2-aryl-propionamides, useful in the inhibition of il-8 induced chemiotaxis of neutrophils
11/11/2009CN101578294A Inhibitors of hepatitis C virus
11/11/2009CN101578120A Compounds and compositions as channel activating protease inhibitors
11/11/2009CN101575360A Method for separating and washing aspartame
11/11/2009CN100558742C Peptide gap junction modulators
11/11/2009CN100558395C Hybrid peptide modulate immune response
11/10/2009US7615533 Peptide compounds derivatized with a hydrophilic polymer; solubility and circulation half-lives are increased and their immunogenicity is masked
11/10/2009US7615368 Microarrays of polypeptides
11/10/2009US7615359 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
11/10/2009US7615244 Glycopeptide and peptide having a kokumi taste imparting function, and method of imparting the kokumi taste to foods
11/05/2009WO2009135015A2 Improved methods and compositions for f-18 labeling of proteins, peptides and other molecules
11/05/2009WO2009132585A1 A novel anti-aging skincare cream, the cosmetic device and cream within
11/05/2009WO2008106080A9 Synthesis of desacetoxytubulysin h and analogs thereof
11/05/2009WO2007112345A8 Use of cyclosporin alkene analogues for preventing or treating viral-induced disorders
11/05/2009US20090275728 Compound having histone deacetylase-inhibiting activity, and pharmaceutical composition comprising the compound as an active ingredient
11/05/2009US20090275727 Peptide turn mimetics
11/05/2009US20090275664 Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
11/05/2009US20090275500 Peptide-containing food intake regulator
11/05/2009US20090274713 Cross-linkers and their uses
11/05/2009US20090274656 Hepatitis c virus inhibitors
11/05/2009US20090274648 Hepatitis c virus inhibitors
11/04/2009EP1615613B1 Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors
11/04/2009EP1542716B1 Growth hormone releasing peptides
11/04/2009EP1375664B1 Method for the secretion and production of protein
11/04/2009EP1261623B1 New retinol derivatives, the method of preparations and the uses thereof
11/03/2009US7612214 Organic amine salts of glutamic acid derivatives and their application
11/03/2009US7612171 DB, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof
11/03/2009US7612166 Fluorous capping reagents and methods for peptide purification
11/03/2009US7612044 biodrug contains an immunogenic peptide; encoded from an isolated host cell transfected with the recombinant expression vector; diagnosis of skin cancer; vaccine for prevention and treatment; immunotherapy
11/03/2009US7612039 From polyoma virus; replication-defective
11/03/2009US7612036 Such as methyl (2S,5S,8R/S)-8-acetamido-2-allyl-9-[6-allyl-9-tert-butoxycarbonyl-9H-carbazol-3-yl]-3,6-diaza-5-{3-[(2,2,5,7,8-pentamethylchroman-6-sulfonyl)-guanidino]propyl}-4,7-dioxononanoate; for treatment of bacterial infections, such as those caused by vancomycin resistant microorganisms
11/03/2009US7611880 Enzymatic ammonolysis process for the preparation of intermediates for DPP IV inhibitors
1 ... 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 ... 307